Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q2

2934.TEDINET S100PYFW
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥9.1bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income−¥368m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥264m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income−¥382m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥713m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax−¥382m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥238m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥349m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥156m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥308m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥156m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥7.8bnat 2022-11-30Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total assets¥5.5bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥3.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.2bnat 2022-11-30Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥4.3bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥2.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥594m2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥288m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥800m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥77m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.3bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.8bn2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-76.452022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-47.822022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.312021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥19.012021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥34.332021-06-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio50.9%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.9%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 31
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥277m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥3.0bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.9bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥84m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥55m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥266m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥181,000
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥412m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥9.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2022-11-30¥84m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30−¥91m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥195m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥64m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥391m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥459m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 489
ItemContextValueUnit
Long term loans payablePrior1YearInstant446069000JPY
Long term loans payableCurrentQuarterInstant1280181000JPY
Other nclPrior1YearInstant13989000JPY
Other nclCurrentQuarterInstant41652000JPY
Noncurrent liabilitiesPrior1YearInstant460058000JPY
Noncurrent liabilitiesCurrentQuarterInstant1404833000JPY
LiabilitiesPrior1YearInstant1903753000JPY
LiabilitiesCurrentQuarterInstant3623547000JPY
Capital stockPrior1YearInstant1486978000JPY
Capital stockCurrentQuarterInstant138358000JPY
Capital surplusPrior1YearInstant1469978000JPY
Capital surplusCurrentQuarterInstant2995741000JPY
Retained earningsPrior1YearInstant1630954000JPY
Retained earningsCurrentQuarterInstant1281520000JPY
Treasury stockPrior1YearInstant-452200000JPY
Treasury stockCurrentQuarterInstant-452358000JPY
Shareholders equityPrior1YearInstant4135711000JPY
Shareholders equityCurrentQuarterInstant3963260000JPY
Subscription rights to sharesPrior1YearInstant904000JPY
Subscription rights to sharesCurrentQuarterInstant10772000JPY
Non controlling interestsPrior1YearInstant20168000JPY
Non controlling interestsCurrentQuarterInstant188020000JPY
Net assetsPrior1YearInstant4156784000JPY
Net assetsCurrentQuarterInstant4162053000JPY
Liabilities and net assetsPrior1YearInstant6060538000JPY
Liabilities and net assetsCurrentQuarterInstant7785601000JPY
Net salesPrior1YTDDuration3912686000JPY
Net salesCurrentYTDDuration9103908000JPY
Cost of salesPrior1YTDDuration1045789000JPY
Cost of salesCurrentYTDDuration5741168000JPY
Gross profitPrior1YTDDuration2866896000JPY
Gross profitCurrentYTDDuration3362739000JPY
Selling general and administrative expensesPrior1YTDDuration2603377000JPY
Selling general and administrative expensesCurrentYTDDuration3730720000JPY
Operating incomePrior1YTDDuration263518000JPY
Operating incomeCurrentYTDDuration-367980000JPY
Interest income noiPrior1YTDDuration8000JPY
Interest income noiCurrentYTDDuration35000JPY
Dividends income noiPrior1YTDDuration0JPY
Dividends income noiCurrentYTDDuration72000JPY
Subsidy income noi bountyPrior1YTDDuration－JPY
Subsidy income noi bountyCurrentYTDDuration2134000JPY
Other noiPrior1YTDDuration316000JPY
Other noiCurrentYTDDuration3329000JPY
Non operating incomePrior1YTDDuration325000JPY
Non operating incomeCurrentYTDDuration5571000JPY
Interest expenses noePrior1YTDDuration179000JPY
Interest expenses noeCurrentYTDDuration5095000JPY
Provision of allowance for doubtful accounts noePrior1YTDDuration238000JPY
Provision of allowance for doubtful accounts noeCurrentYTDDuration455000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass